Michael I. Jesson

2.1k citations
22 papers · 1.8k · 2 hit papers · h-index 14

Impact in

    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Oncology top 5%
    • Cytokine Signaling Pathways and Interactions
    • Peptidase Inhibition and Analysis

Papers in

    • Cytokine Signaling Pathways and Interactions 6
    • Peptidase Inhibition and Analysis 4
    • Immune Cell Function and Interaction 4
    • T-cell and B-cell Immunology 2

Michael I. Jesson

22 papers receiving 1.7k citations

Michael I. Jesson's Hit Papers

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) 2011 · 536 citations
5360+5+10Years since publication100200300400500

Peers

Michael I. Jesson
Comparison fields: 5 of 90
  • Rheumatology 517
  • Oncology 644
  • Immunology 437
  • Hematology 193
  • Genetics 173
Replace Debra M. Meyer with:
Debra M. Meyer United States
Jean S. Beebe United States
Frédéric Vanhoutte Belgium
Lydia Nakopoulou Greece
Toril Holien Norway
Gabriela Motyckova United States
Edward M. Newman United States
Keita Kirito Japan
María Aparecida Nagai Brazil
James R. Dilks United States
Michael I. Jesson relative to Debra M. Meyer United States Debra M. Meyer's profile →
Citations per field
00.5×1.5×1.8×
Debra M. Meyer · 1×
Citations per year

Countries citing papers authored by Michael I. Jesson

Since Specialization
Citations

This map shows the geographic impact of Michael I. Jesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael I. Jesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael I. Jesson more than expected).

Fields of papers citing papers by Michael I. Jesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael I. Jesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael I. Jesson. The network helps show where Michael I. Jesson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael I. Jesson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael I. Jesson Line = papers co-authored together Michael I. Jesson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Hit paper breakdown →
2011536
2
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
Hit paper breakdown →
2010402
3 2004176
4 2019125
5 2012120
6 201394
7 201983
8 200349
9 201443
10 201826
11 201023
12
Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin.
198915
13
Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells.
198715
14 200313
15 201912
16 199311
17 19969
18 19988
19
Immune mechanism of action of talabostat: a dipeptidyl peptidase targeted antitumor agent
20076
20 19976

About Michael I. Jesson

Michael I. Jesson is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), Immune Cell Function and Interaction (4 papers), Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (3 papers), Diabetes and associated disorders (2 papers), T-cell and B-cell Immunology (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Rheumatology (517 citations), Oncology (644 citations), Immunology (437 citations), Hematology (193 citations) and Genetics (173 citations). Michael I. Jesson has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Martin E. Dowty, Debra M. Meyer, Nandini Kishore, Barry Jones, Sarbani Ghosh, Sharlene Adams, Glenn T. Miller, Barbara Wallner, Takeshi Watanabe and Timothy P. LaBranche. Their work appears in journals such as Cancer Research, The Journal of Immunology, ACS Chemical Biology, International Immunology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact